F18.921 Inhalant use, unspecified with intoxication with delirium

Name of the Condition

• Common Name: Inhalant Use Disorder with Intoxication and Delirium
• Medical Term: Inhalant Use, Unspecified with Intoxication with Delirium

Summary

Inhalant use, unspecified with intoxication with delirium, refers to the misuse of inhalants—substances that produce chemical vapors—for their psychoactive effects, accompanied by acute intoxication and delirium. This condition involves the intentional inhalation of substances like glue, paint thinners, or aerosols, leading to immediate physical and psychological effects, including confusion, disorientation, and altered consciousness. Inhalant use may result in significant harm, affecting an individual's health and daily functioning.

Causes

Inhalant use is primarily driven by the repeated misuse of inhalants for their psychoactive effects. Inhalants are often everyday household or industrial products, such as glue, paint thinners, aerosols, or solvents. The misuse of these substances can lead to dependence and related health issues, including acute intoxication and delirium.

Risk Factors

• Adolescents and young adults are more likely to experiment with inhalants.
• Individuals with a history of substance abuse or mental health disorders.
• Accessibility to inhalant products.
• Lack of proper supervision or guidance.

Symptoms

• Intense cravings or compulsive inhalant use.
• Coordination problems, dizziness, or lethargy.
• Unexplained behavioral changes such as aggression or mood swings.
• Cognitive impairment.
• Confusion, disorientation, or altered consciousness (delirium).

Diagnosis

Diagnosis involves a clinical evaluation of symptoms, including a history of inhalant use and the presence of intoxication with delirium. Healthcare providers assess the individual's mental status, physical symptoms, and potential exposure to inhalants. Laboratory tests may be used to rule out other causes of delirium or intoxication.

Treatment Options

Treatment focuses on managing acute symptoms, such as delirium, and addressing the underlying inhalant use. This may include supportive care, monitoring, and interventions to stabilize the individual. Long-term treatment often involves behavioral therapy, counseling, and support for substance use disorders.

Prognosis and Follow-Up

Prognosis depends on the severity of intoxication and delirium, as well as the individual's response to treatment. Follow-up care is essential to monitor for recurrence of use, manage withdrawal symptoms, and address any ongoing mental health or physical health issues.

Complications

• Respiratory distress or failure.
• Neurological damage.
• Organ damage (e.g., liver, kidneys).
• Increased risk of accidents or injuries due to impaired judgment.
• Worsening of mental health conditions.

Lifestyle & Prevention

• Avoiding exposure to inhalant products.
• Educating individuals, especially adolescents, about the risks of inhalant use.
• Providing alternative coping mechanisms for stress or peer pressure.
• Ensuring proper supervision and storage of household chemicals.

When to Seek Professional Help

Seek immediate medical attention if experiencing confusion, disorientation, or altered consciousness after inhalant use. Contact a healthcare provider for ongoing substance use concerns or if symptoms of intoxication or delirium persist.

Tips for Medical Coders

Document the presence of inhalant use, intoxication, and delirium clearly in the medical record. Ensure the diagnosis aligns with clinical findings and specify any contributing factors. Code F18.921 is appropriate when inhalant use is unspecified, intoxication is present, and delirium is a key feature.